ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

CDC to Revise Opioid Guidelines for Those With Chronic Pain

Updated on October 20, 2015

According to the American Academy of Pain Medicine, there are around 100 million people in the country who suffer from chronic pain (1). Many of these people take opioids to help manage the pain, but due to the current guidelines being controversial, the Centers for Disease Control and Prevention (CDC) has decided that it’s time to make some revisions. This effort is a move that is meant to help combat the issues associated with opioid abuse, overuse, and overdose.

The CDC reports that 259 million opioid prescriptions are filled per year, which represents a 300 percent increase since 1999, although the amount of pain that people report having has not gone up. They estimate that around 2 million Americans abuse or are dependent on prescription drugs, and around 16,000 people die each year in the country due to opioid-related overdoses (2).

The prescription drug abuse and overdose issue has moved to the center stage, prompting the CDC to seek ways to help reduce those numbers. Its goal in revising the guidelines is to help provide people with a safer and effective way to help manage their pain, but yet also bring about a reduction in the misuse, abuse, and overdoses that are taking place each year.

The guideline revisions are for those suffering from non-cancer chronic pain and do not include end-of-life care. The CDC draft, which will be finalized in January 2016, focuses on determining when to initiate or continue opioids, selection, dosage, duration, and discontinuation, as well as assessing the risks of taking them. Additionally, the draft guidelines suggest non-pharmacologic therapy and non-opioid pharmacologic therapy.

While working on finalizing the guidelines that will be released, the draft the CDC has issued has sparked some controversy. Some advocacy groups have voiced their concerns over the guidelines in that they may make it difficult for patients to effectively manage their chronic pain, and that the guidelines are being devised using poor evidence and that the process lacks transparency(3). In creating the new guidelines, the CDC invited a variety of groups to attend a webinar on the issue, including those representing physicians, insurance companies, pharmacists, and various advocacy groups.

Stay tuned for the final guidelines to be released in January, when we will all see how they may impact those suffering from non-cancer chronic pain.


Sources:

1. American Academy of Pain Medicine. Facts and Figures on Pain. <http://www.painmed.org/patientcenter/facts_on_pain.aspx>

2. Center for Disease Control and Prevention. Draft CDC Guideline for Prescribing Opiods for Chronic Pain. <http://www.cdc.gov/drugoverdose/prescribing/guideline.html>

3. Cancer Action Network. CDC Opioid Guidelines Process Relies on Poor Evidence, Lacks Transparency. <http://www.acscan.org/content/media-center/cdc-opioid-guidelines-process-relies-on-poor-evidence-lacks-transparency/>

Comments

    0 of 8192 characters used
    Post Comment

    No comments yet.

    working

    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: https://hubpages.com/privacy-policy#gdpr

    Show Details
    Necessary
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
    Features
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Marketing
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Statistics
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)